Literature DB >> 15070905

Clinical review 166: Growth hormone receptor antagonists.

Alex F Muller1, John J Kopchick, Allan Flyvbjerg, Aart Jan van der Lely.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070905     DOI: 10.1210/jc.2002-022049

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  18 in total

Review 1.  GH receptor antagonist: mechanism of action and clinical utility.

Authors:  Sowmya K Surya; Ariel L Barkan
Journal:  Rev Endocr Metab Disord       Date:  2005-01       Impact factor: 6.514

Review 2.  Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs.

Authors:  Suphiya Parveen; Sanjeeb K Sahoo
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 3.  Acromegaly.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Endocrinol Metab Clin North Am       Date:  2008-03       Impact factor: 4.741

Review 4.  The management of the patient with acromegaly and headache: a still open clinical challenge.

Authors:  A Giustina; M Gola; A Colao; L De Marinis; M Losa; N Sicolo; E Ghigo
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

5.  Optimal use of pegvisomant in acromegaly: are we getting there?

Authors:  Andrea Giustina
Journal:  Endocrine       Date:  2014-10-28       Impact factor: 3.633

6.  Effect of rosiglitazone on serum IGF-I concentrations in uncontrolled acromegalic patients under conventional medical therapy: results from a pilot phase 2 study.

Authors:  F Bogazzi; G Rossi; M Lombardi; F Raggi; C Urbani; C Sardella; C Cosci; E Martino
Journal:  J Endocrinol Invest       Date:  2010-07-29       Impact factor: 4.256

7.  Properties of antibodies to a synthetic peptide representing an epitope shared by receptors of the type I cytokine family.

Authors:  Carlos G Belloc; Marisol Aguirre; Clara Peña; José L Aparicio; Maite Duhalde Vega; Sarah Dormois; Lilia A Retegui
Journal:  Clin Exp Med       Date:  2013-02       Impact factor: 3.984

8.  Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex.

Authors:  Jie Xu; Yue Zhang; Philip A Berry; Jing Jiang; Peter E Lobie; John F Langenheim; Wen Y Chen; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2011-02-10

9.  Development and characterization of high affinity leptins and leptin antagonists.

Authors:  Michal Shpilman; Leonora Niv-Spector; Meirav Katz; Chen Varol; Gili Solomon; Michal Ayalon-Soffer; Eric Boder; Zamir Halpern; Eran Elinav; Arieh Gertler
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

10.  Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly.

Authors:  Antonio Bianchi; Gherardo Mazziotti; Laura Tilaro; Vincenzo Cimino; Flora Veltri; Eleonora Gaetani; Giovanni Pecorini; Alfredo Pontecorvi; Andrea Giustina; Laura De Marinis
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.